nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—hindlimb—leprosy	0.111	0.21	CbGeAlD
Dabigatran etexilate—F2—appendage—leprosy	0.0948	0.18	CbGeAlD
Dabigatran etexilate—F2—blood vessel—leprosy	0.0528	0.1	CbGeAlD
Dabigatran etexilate—CES2—eye—leprosy	0.0313	0.0595	CbGeAlD
Dabigatran etexilate—F2—eye—leprosy	0.0281	0.0533	CbGeAlD
Dabigatran etexilate—CES2—skin of body—leprosy	0.0273	0.0517	CbGeAlD
Dabigatran etexilate—CES2—tendon—leprosy	0.0207	0.0394	CbGeAlD
Dabigatran etexilate—NQO2—tendon—leprosy	0.0185	0.0352	CbGeAlD
Dabigatran etexilate—UGT2B7—testis—leprosy	0.0172	0.0326	CbGeAlD
Dabigatran etexilate—CES2—testis—leprosy	0.0172	0.0326	CbGeAlD
Dabigatran etexilate—CES2—nervous system—leprosy	0.0169	0.032	CbGeAlD
Dabigatran etexilate—Thrombosis—Thalidomide—leprosy	0.0165	0.0348	CcSEcCtD
Dabigatran etexilate—NQO2—testis—leprosy	0.0153	0.0291	CbGeAlD
Dabigatran etexilate—F2—nervous system—leprosy	0.0151	0.0287	CbGeAlD
Dabigatran etexilate—NQO2—nervous system—leprosy	0.0151	0.0286	CbGeAlD
Dabigatran etexilate—Nasopharyngitis—Dapsone—leprosy	0.0148	0.0313	CcSEcCtD
Dabigatran etexilate—Influenza—Dapsone—leprosy	0.0143	0.0302	CcSEcCtD
Dabigatran etexilate—CES1—testis—leprosy	0.0141	0.0268	CbGeAlD
Dabigatran etexilate—CES1—nervous system—leprosy	0.0139	0.0264	CbGeAlD
Dabigatran etexilate—Bone disorder—Thalidomide—leprosy	0.0129	0.0273	CcSEcCtD
Dabigatran etexilate—Hyperbilirubinaemia—Thalidomide—leprosy	0.0128	0.0271	CcSEcCtD
Dabigatran etexilate—Sinusitis—Dapsone—leprosy	0.012	0.0253	CcSEcCtD
Dabigatran etexilate—ABCB1—blood vessel—leprosy	0.0114	0.0216	CbGeAlD
Dabigatran etexilate—Oesophagitis—Thalidomide—leprosy	0.0107	0.0225	CcSEcCtD
Dabigatran etexilate—Cardiac failure congestive—Thalidomide—leprosy	0.00934	0.0197	CcSEcCtD
Dabigatran etexilate—Cough—Dapsone—leprosy	0.00869	0.0184	CcSEcCtD
Dabigatran etexilate—Cardiac failure—Thalidomide—leprosy	0.00868	0.0183	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Thalidomide—leprosy	0.00847	0.0179	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00847	0.0179	CcSEcCtD
Dabigatran etexilate—Pain in extremity—Thalidomide—leprosy	0.00847	0.0179	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Thalidomide—leprosy	0.00782	0.0165	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00763	0.0161	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Thalidomide—leprosy	0.00747	0.0158	CcSEcCtD
Dabigatran etexilate—Influenza—Thalidomide—leprosy	0.00732	0.0155	CcSEcCtD
Dabigatran etexilate—Dysphagia—Thalidomide—leprosy	0.00732	0.0155	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Thalidomide—leprosy	0.0072	0.0152	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Thalidomide—leprosy	0.00713	0.0151	CcSEcCtD
Dabigatran etexilate—Bronchitis—Thalidomide—leprosy	0.00704	0.0149	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Thalidomide—leprosy	0.0068	0.0144	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Dapsone—leprosy	0.00665	0.0141	CcSEcCtD
Dabigatran etexilate—Pneumonia—Thalidomide—leprosy	0.00656	0.0139	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Thalidomide—leprosy	0.00653	0.0138	CcSEcCtD
Dabigatran etexilate—Infestation—Thalidomide—leprosy	0.00653	0.0138	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Thalidomide—leprosy	0.00643	0.0136	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Dapsone—leprosy	0.00643	0.0136	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Thalidomide—leprosy	0.0064	0.0135	CcSEcCtD
Dabigatran etexilate—Haematuria—Thalidomide—leprosy	0.00622	0.0132	CcSEcCtD
Dabigatran etexilate—Epistaxis—Thalidomide—leprosy	0.00616	0.013	CcSEcCtD
Dabigatran etexilate—Sinusitis—Thalidomide—leprosy	0.00612	0.0129	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Thalidomide—leprosy	0.00579	0.0122	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Thalidomide—leprosy	0.00577	0.0122	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Thalidomide—leprosy	0.00574	0.0121	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Thalidomide—leprosy	0.00544	0.0115	CcSEcCtD
Dabigatran etexilate—Angiopathy—Thalidomide—leprosy	0.00532	0.0112	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Thalidomide—leprosy	0.00529	0.0112	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Thalidomide—leprosy	0.00528	0.0112	CcSEcCtD
Dabigatran etexilate—Vomiting—Dapsone—leprosy	0.00517	0.0109	CcSEcCtD
Dabigatran etexilate—Malnutrition—Thalidomide—leprosy	0.0051	0.0108	CcSEcCtD
Dabigatran etexilate—Headache—Dapsone—leprosy	0.00509	0.0108	CcSEcCtD
Dabigatran etexilate—Flatulence—Thalidomide—leprosy	0.00503	0.0106	CcSEcCtD
Dabigatran etexilate—Back pain—Thalidomide—leprosy	0.00493	0.0104	CcSEcCtD
Dabigatran etexilate—Nausea—Dapsone—leprosy	0.00483	0.0102	CcSEcCtD
Dabigatran etexilate—Anaemia—Thalidomide—leprosy	0.00471	0.00996	CcSEcCtD
Dabigatran etexilate—Angioedema—Thalidomide—leprosy	0.00466	0.00985	CcSEcCtD
Dabigatran etexilate—Syncope—Thalidomide—leprosy	0.00457	0.00967	CcSEcCtD
Dabigatran etexilate—Palpitations—Thalidomide—leprosy	0.00451	0.00952	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Thalidomide—leprosy	0.00448	0.00947	CcSEcCtD
Dabigatran etexilate—Cough—Thalidomide—leprosy	0.00445	0.00941	CcSEcCtD
Dabigatran etexilate—Hypertension—Thalidomide—leprosy	0.0044	0.00931	CcSEcCtD
Dabigatran etexilate—Chest pain—Thalidomide—leprosy	0.00434	0.00918	CcSEcCtD
Dabigatran etexilate—Arthralgia—Thalidomide—leprosy	0.00434	0.00918	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00431	0.00911	CcSEcCtD
Dabigatran etexilate—Infection—Thalidomide—leprosy	0.00414	0.00874	CcSEcCtD
Dabigatran etexilate—Shock—Thalidomide—leprosy	0.0041	0.00865	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Thalidomide—leprosy	0.00408	0.00863	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Thalidomide—leprosy	0.00408	0.00861	CcSEcCtD
Dabigatran etexilate—Skin disorder—Thalidomide—leprosy	0.00404	0.00854	CcSEcCtD
Dabigatran etexilate—Hypotension—Thalidomide—leprosy	0.00389	0.00822	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Thalidomide—leprosy	0.00379	0.00801	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Thalidomide—leprosy	0.00371	0.00784	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Thalidomide—leprosy	0.00366	0.00774	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Thalidomide—leprosy	0.00359	0.00759	CcSEcCtD
Dabigatran etexilate—Fatigue—Thalidomide—leprosy	0.00359	0.00758	CcSEcCtD
Dabigatran etexilate—Constipation—Thalidomide—leprosy	0.00356	0.00752	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Thalidomide—leprosy	0.0034	0.00719	CcSEcCtD
Dabigatran etexilate—ABCB1—testis—leprosy	0.00331	0.00629	CbGeAlD
Dabigatran etexilate—Urticaria—Thalidomide—leprosy	0.00331	0.00699	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Thalidomide—leprosy	0.00329	0.00695	CcSEcCtD
Dabigatran etexilate—ABCB1—nervous system—leprosy	0.00325	0.00617	CbGeAlD
Dabigatran etexilate—Hypersensitivity—Thalidomide—leprosy	0.00307	0.00648	CcSEcCtD
Dabigatran etexilate—Asthenia—Thalidomide—leprosy	0.00299	0.00631	CcSEcCtD
Dabigatran etexilate—Pruritus—Thalidomide—leprosy	0.00294	0.00622	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Thalidomide—leprosy	0.00285	0.00602	CcSEcCtD
Dabigatran etexilate—Dizziness—Thalidomide—leprosy	0.00275	0.00582	CcSEcCtD
Dabigatran etexilate—Vomiting—Thalidomide—leprosy	0.00265	0.00559	CcSEcCtD
Dabigatran etexilate—Rash—Thalidomide—leprosy	0.00262	0.00555	CcSEcCtD
Dabigatran etexilate—Dermatitis—Thalidomide—leprosy	0.00262	0.00554	CcSEcCtD
Dabigatran etexilate—Headache—Thalidomide—leprosy	0.00261	0.00551	CcSEcCtD
Dabigatran etexilate—Nausea—Thalidomide—leprosy	0.00247	0.00523	CcSEcCtD
